Kenneth Kalunian Selected Research

Kenneth Kalunian Research Topics

Disease

19	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 08/2006
6	Lupus Nephritis 03/2024 - 08/2012
5	Rheumatoid Arthritis 01/2022 - 08/2006
4	Infections 01/2024 - 04/2013
3	Herpes Zoster 01/2019 - 11/2016
2	Neoplasms (Cancer) 01/2024 - 01/2019
2	Inflammation (Inflammations) 01/2024 - 08/2006
2	Proteinuria 01/2024 - 01/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Seizures (Absence Seizure) 01/2023
1	Cutaneous Lupus Erythematosus 01/2022
1	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2022
1	Fatigue 01/2019
1	Tuberculosis (Tuberculoses) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Nasopharyngitis 01/2019
1	Headache (Headaches) 01/2019
1	Retinal Vein Occlusion 01/2019
1	Human Influenza (Influenza) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2014
1	Hyperlipidemias (Hyperlipidemia) 08/2014
1	Hypertension (High Blood Pressure) 08/2014
1	Vitamin D Deficiency 08/2014
1	Sjogren's Syndrome (Sjogren Syndrome) 01/2014
1	Autoimmune Diseases (Autoimmune Disease) 06/2009
1	Injection Site Reaction 12/2007
1	Atherosclerosis 08/2006
1	Giant Cell Arteritis (Horton Disease) 05/2002

Drug/Important Bio-Agent (IBA)

5	Monoclonal AntibodiesIBA 01/2022 - 04/2013
4	InterferonsIBA 01/2021 - 04/2013
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2024 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2012
3	AutoantibodiesIBA 01/2023 - 06/2009
3	AntibodiesIBA 01/2016 - 08/2012
2	Adenosine Monophosphate (AMP)IBA 03/2024 - 01/2024
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2024 - 01/2023
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2006
2	GlucocorticoidsIBA 01/2023 - 12/2021
2	Interferon Type IIBA 01/2022 - 01/2017
2	GLPG0634IBA 01/2022 - 01/2019
2	AntigensIBA 01/2022 - 01/2014
2	CreatinineIBA 08/2020 - 01/2019
2	C-Reactive ProteinIBA 01/2019 - 08/2014
2	sifalimumabIBA 11/2016 - 04/2013
2	Complement C3 (C3 Complement)IBA 01/2016 - 01/2014
2	epratuzumabIBA 01/2014 - 07/2013
1	TeratogensIBA 01/2024
1	Antiphospholipid AntibodiesIBA 01/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2023
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Codon (Codons)IBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2021
1	belimumabIBA 01/2021
1	Antirheumatic Agents (DMARD)IBA 01/2019
1	Nucleosomes (Nucleosome)IBA 12/2017
1	anifrolumabIBA 01/2017
1	hydroxide ionIBA 08/2014
1	25-hydroxyvitamin DIBA 08/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	complement C4dIBA 01/2014
1	Antinuclear AntibodiesIBA 08/2012
1	Immunoglobulins (Immunoglobulin)IBA 12/2007
1	TACI receptor-IgG Fc fragment fusion proteinIBA 12/2007
1	oxidized low density lipoproteinIBA 08/2006
1	HDL LipoproteinsIBA 08/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2002
1	Methotrexate (Mexate)FDA LinkGeneric 05/2002

Therapy/Procedure

3	Therapeutics 01/2024 - 01/2017
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2019